Infectious Disease/Inflammatory

Infectious diseases are disorders which are caused by organisms such as viruses, bacteria, fungi, or parasites. Many organisms live in and on our bodies without causing health issues. In some circumstances, however, some organisms may cause disease. Just like each infectious disease has its own specific signs and symptoms, there are best practices for diagnostic criteria, testing, and treatment for each.
Abstract Clinical Education Article Clinical Education Webinar Health Trends™ Report Peer-Reviewed Study Research Findings Article Research Findings Chart Research Findings Map Testing Guide

 

Type Title Category Year
Infectious Disease/Inflammatory: Allergies
Health Trends Report

Allergies Across America™: The Largest Study of Allergy Testing in the United States In Allergies Across America, Quest Diagnostics provides results of the largest analysis of allergy testing on patients in the United States who are under medical evaluation for symptoms associated with allergies...

Allergies Download >
2011 +
Testing
Guide

Allergens by the numbers: Testing for whole allergen proteins can help you better diagnose allergies/sensitizations and prepare personalized management plans. Testing for whole allergen proteins can help you better diagnose allergies/sensitizations and prepare personalized management plans. Use this testing guide, complete with test names and codes, to select an allergy testing regimen for your patients...

Allergies Download >
2017 +
Infectious Disease/Inflammatory: Arthritis
Clinical
Education Webinar

The Appropriate Use of Diagnostic Testing in the Management of Rheumatoid Arthritis Martin J. Bergman, MD, Clinical Associate Professor of Medicine, Drexel University College of Medicine, Philadephia, PAMD, discusses the seriousness of a diagnosis of rheumatoid arthritis for patients who are afflicted and the appropriate use and limitations of laboratory testing in the diagnosis and monitoring for rheumatoid disease...

Arthritis Watch >
2012 +
Abstract

Serum 14-3-3η is a Novel Marker that Complements Current Serological Measurements to Enhance Detection of Patients with Rheumatoid Arthritis Researchers from Quest Diagnostics (NYSE: DGX) and other institutions found that elevated blood-serum levels of the 14- 3-3eta protein outperformed conventional antibody-serum testing, including rheumatoid factor (RF) and anti-citrullinated peptide antibodies (ACPA, also known as antibodies to cyclic citrullinated peptides or CCP), for the identification of RA...

Arthritis View >
2014 +
Infectious Disease/Inflammatory: Autoimmune Disease
Clinical
Education Webinar

14-3-3eta Protein: A New Direction in the Early Diagnosis of Rheumatoid Arthritis Dr. Walter Maksymowych, Scientist, Alberta Heritage Foundation for Medical Research, Consultant Rheumatologist and Professor of Medicine, University of Alberta, Edmonton, discusses the diagnostic and prognostic value of the 14-3-3eta protein in rheumatoid arthritis and the clinical relevance of a new assay that measures this biomarker...

Autoimmune Disease Watch >
2013 +
Clinical
Education Webinar

ANA – The Misunderstood Lab Test Bergman, Martin J., MD, Clinical Associate Professor of Medicine, Drexel University College of Medicine, Philadephia, PA discusses the primary screen and testing for autoimmune diseases...

Autoimmune Disease Watch >
2016 +
Research
Findings Chart

Autoantibody Prevalence in Autoimmune Diseases Physician Reference Guide: Autoantibody disease prevalence, autoantibody, and diagnostic criteria...

Autoimmune Disease Download >
2016 +
Infectious Disease/Inflammatory: Infectious Disease
Clinical
Education Article

A New Algorithm for HIV Laboratory Testing Bernard M. Branson, MD, Associate Director for Laboratory Diagnostics, Office of the Director, Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention discusses the rationale for developing the new algorithm. He explains how it will enable earlier detection of HIV infection and reduce the number of indeterminate results, leading to improved patient management and long-term outcomes...

Infectious Disease View >
2014 +
Clinical
Education Article

Chikungunya: A Growing Public Health Concern for the United States Dr. Holly Batterman, Medical Director, Focus Diagnostics, a Quest Diagnostics subsidiary, discusses the epidemiology and clinical features of chikungunya infection, reviews its diagnostic challenges and discusses the implications of the outbreak for health care providers in the United States...

Infectious Disease View >
2014 +
Peer-Reviewed Study

Geographic Disparities in Access to Syringe Services Programs Among Young Persons with Hepatitis C Virus Infection in the United States 80% of 29382 young persons currently infected with hepatitis C virus lived >10 miles from a syringe services program, as reported by Dr. Harvey W. Kaufman, senior medical director at Quest Diagnostics, Randall Young, MA, Division of Toxicology and Human Health Sciences, Agency for Toxic Substances and Disease Registry, CDC...

Infectious Disease View >
2017 +
Clinical Education Webinar

H pylori: Gaps in Care Ali M. Amir, MD, Staff Gastroenterologist, Assistant Professor of Medicine, George Washington University, Washington, DC discusses important information to medical professionals on the appropriate diagnosis and treatment for early onset of H pylori, why testing prior to prescribing a proton pump inhibitor is essential for optimal patient care and helps attendees understand the importance of H pylori eradication....

Infectious Disease Watch >
2014 +
Health Trends™ Report

H1N1 Testing in America: After the Pandemic’s Peak Decline in testing demand, positivity rates suggest the end of pandemic’s peak in 2009...

Infectious Disease Download >
2010 +
Health Trends™ Report

H1N1 Testing in America: H1N1 the Dominant Flu of 2009-2010 Findings suggest the H1N1 virus has “crowded out” other flu viruses, to be virtually the only influenza virus circulating in the US since it was first identified in April 2009...

Infectious Disease Download >
2010 +
Research
Finding Article

Hepatitis A surveillance using commercial laboratory data Laboratory data from Quest Diagnostics and Laboratory Corporation of America was used to monitor trends in HAV infections over time and identify geographic and demographic characteristics of HAV case clusters for the propose of targeting interventions...

Infectious Disease View >
2018 +
Peer-Reviewed Study

Trends in Hepatitis B infection and immunity among women of childbearing age in the United States A retrospective analysis of HBV status among women of childbearing age nationally and by state was conducted utilizing the Quest Diagnostics database. Rates of HBV in women born before and after implementation of universal HBV vaccination recommendations were determined...

Infectious Disease View >
2019 +
Research
Findings Article

Hepatitis C—Diagnosis and Cure With about 71 million people infected worldwide, chronic hepatitis C virus (HCV) infection is a global health problem. HCV infection increases the risk of liver fibrosis, cirrhosis, and liver cancer, and is responsible for almost 400,000 deaths annually...

Infectious Disease Download >
2018 +
Peer-Reviewed Study

Laboratory Blood-Based Testing for Lyme Disease at a National Reference Laboratory: A 7-Year Experience (2010-2016) Positive tests were observed in all 50 states and the District of Columbia. New York had the most positive tests, whereas Connecticut had the highest positivity rate when normalized to state populations. Some states with historically low rates of LD (eg, Texas, Florida, and California) showed significant increases in testing and positivity rates over time...

Infectious Disease View >
2016 +
Peer-Reviewed Study

Laboratory blood-based testing for non-Lyme Disease tick-borne infections at a national reference laboratory: a 7-year experience (2010-2016) Testing and positivity for most non-Lyme disease tick-borne diseases (NLTBI) increased dramatically from 2010 through 2016, generally exceeding the number of positive cases reported by the Centers for Disease Control and Prevention...

Infectious Disease Watch >
2019 +
Abstract

Measuring trends in hepatitis C testing with commercial laboratory data Using the 2 largest commercial laboratory data sources nationally, we estimated the annual rates of hepatitis C testing among individuals who were recommended to be tested (i.e., baby boomer cohort born between 1945 and 1965) by the CDC and United States Preventive Services Task Force...

Infectious Disease View >
2019 +
Research
Findings Article

Preventing HIV: PrEP and Laboratory Testing Discussion on PrEP, as well as the role of laboratory testing before and during PrEP. How (PrEP) treatment regimen reduces the risk of HIV infection in uninfected individuals who are at high risk of contracting HIV...

Infectious Disease Download >
2018 +
Peer-Reviewed Study

Q fever: an under-reported reportable communicable disease The objective of this study was to provide real world clinical laboratory based data to supplement Centers for Disease Control and Prevention (CDC) reporting of Q fever. Dr. Harvey W. Kaufman, senior medical director at Quest Diagnostics...

Infectious Disease View >
2019 +
Health Trends™ Report

Health Trends™: Lyme Disease—Quest data reveal more cases in more places In this Quest Diagnostics Health Trends™ report, Quest identifies rates of Lyme disease based on 6 million deidentified results of immunoglobulin (IgG) laboratory tests...

Infectious Disease Download >
2018 +
Peer-Reviewed Study

The Burden of Hepatitis C Infection-Related Liver Fibrosis in the United States A large proportion of persons infected with HCV do not receive care and only half of those with advanced fibrosis or cirrhosis are evaluated for treatment. Xiaohau Huang, Strategic Initiatives and Data Analytics, Quest Diagnostics, West Norriton, PA...

Infectious Disease View >
2016 +
Testing
Guide

TBBloodTesting.com The CDC and other medical organizations prefer interferon-gamma release assays (IGRAs) for certain patient populations—here’s why you should, too...

Infectious Disease View >
2019 +
Clinical Education Webinar

Tick-Borne Illness: An Expert Panel Discussion on Disease States and Diagnostic Testing Options Hema Kapoor, MD, D (ABMM), SM, Director, Medical Science Liaison, infectious Diseases and Immunology leads a panel discussion on tick-borne diseases with some of the leading infectious disease experts from Quest Diagnostics...

Infectious Disease Watch >
2018 +
Abstract

Trends in HIV-1 drug resistance mutations from a US reference laboratory: 2006-2017 Trends in resistance to antiretroviral drugs for HIV-1 may inform clinical support and drug development. Drug resistance mutations (DRM) trends for nucleoside reverse transcriptase inhibitor (NRTI), nonnucleoside reverse transcriptase inhibitor (NNRTI), protease inhibitor (PI), and integrase strand transfer inhibitor (INSTI) were evaluated...

Infectious Disease View >
2019 +
Peer-Reviewed Study

Trends in Laboratory Rotavirus Detection: 2003 to 2014 Dr. Harvey W. Kaufman, senior medical director at Quest Diagnostics, assessed the impact of rotavirus vaccination at national and state levels by evaluating the change in rotavirus antigen detection after vaccination licensure...

Infectious Disease View >
2016 +
Clinical Education Webinar

Zika virus and other mosquito-borne infections in 2016 John A.D. Leake, MD, MPH, Medical Director, Infectious Diseases, discusses the epidemiology of Zika virus, including co-circulating viruses transmitted by Aedes aegypti mosquito, the clinical features of Zika virus and special issues in pregnancy...

Infectious Disease Watch >
2016 +
Peer-Reviewed Study

Increasing number of metabolic co-morbidities are associated with higher risk of advanced fibrosis in patients with non-alcoholic steatohepatitis The presence of fibrosis is the strongest predictor of mortality and liver-related complications among patients with non-alcoholic steatohepatitis (NASH). More accurately understanding the prevalence and predictors of advanced fibrosis among NASH patients is important to guide healthcare resource planning so that adequate preventative care and interventions can be effectively targeted to those NASH patients at greatest risk of liver-related complications...

Infectious Disease View >
2019 +

For more information or if you have any questions, please contact HealthTrends@QuestDiagnostics.com